Abstract
165AbstractOver the past decades advances in bioengineering and expanded insight in tumor immunology have resulted in the emergence of novelbispecific antibody (bsAb) constructs that are capable of redirecting immune effector cells to the tumor microenvironment. (Pre-) clinicalstudies of various bsAb constructs have shown impressive results in terms of immune effector
... read more